Cite
HARVARD Citation
Dadu, R. et al. (2014). Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer. Oncologist. pp. 477-482. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dadu, R. et al. (2014). Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer. Oncologist. pp. 477-482. [Online].